These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 10681670

  • 1. Advanced glycation end-product levels in subtotally nephrectomized rats: beneficial effects of angiotensin II receptor 1 antagonist losartan.
    Sebeková K, Schinzel R, Münch G, Krivosíková Z, Dzúrik R, Heidland A.
    Miner Electrolyte Metab; 1999; 25(4-6):380-3. PubMed ID: 10681670
    [Abstract] [Full Text] [Related]

  • 2. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z, Sebeková K, Spustová V, Lajdová I, Dzúrik R.
    Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
    [Abstract] [Full Text] [Related]

  • 3. Effect of angiotensin II type 1 receptor blockade on conduit artery tone in subtotally nephrectomized rats.
    Kööbi P, Jolma P, Kalliovalkama J, Tikkanen I, Fan M, Kähönen M, Moilanen E, Pörsti I.
    Nephron Physiol; 2004; 96(3):p91-8. PubMed ID: 15056982
    [Abstract] [Full Text] [Related]

  • 4. Ultrastructural changes in the remnant kidney (after 5/6 nephrectomy) glomerulus after losartan and atenolol treatment.
    Aunapuu M, Pechter U, Arend A, Suuroja T, Ots M.
    Medicina (Kaunas); 2003; 39(10):975-9. PubMed ID: 14578640
    [Abstract] [Full Text] [Related]

  • 5. DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan.
    Krivosíková Z, Dusinská M, Spustová V, Sebeková K, Blazícek P, Heidland A, Dzúrik R.
    Kidney Int Suppl; 2001 Feb; 78():S212-5. PubMed ID: 11169013
    [Abstract] [Full Text] [Related]

  • 6. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J, Meng L, Li S, Qu L, Li X.
    Vascul Pharmacol; 2009 Feb; 50(5-6):185-93. PubMed ID: 19563735
    [Abstract] [Full Text] [Related]

  • 7. The effect of oral protease administration in the rat remnant kidney model.
    Sebeková K, Dämmrich J, Krivosíková Z, Heidland A.
    Res Exp Med (Berl); 1999 Dec; 199(3):177-88. PubMed ID: 10639701
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A, Hernández-Perera O, Díaz-Herrera P, Ucero ÁC, Anabitarte-Prieto A, Losada-Cabrera A, Ortiz A, Rodríguez-Pérez JC.
    Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
    [Abstract] [Full Text] [Related]

  • 9. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J, Zhang Z, Liu J, Sun L, Hu L, Cooper ME, Cao Z.
    Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of angiotensin II and the AT(1) receptor antagonist losartan on the renal excretion of urodilatin.
    Heringlake M, Bahlmann L, Klaus S, Wagner K, Schmucker P, Pagel H.
    Kidney Blood Press Res; 2001 Aug; 24(2):79-83. PubMed ID: 11435738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
    Xu C, Ding W, Zhang M, Gu Y.
    Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G, Zatz R.
    Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of neuronal nitric oxide synthase in the rat remnant kidney.
    Roczniak A, Fryer JN, Levine DZ, Burns KD.
    J Am Soc Nephrol; 1999 Apr; 10(4):704-13. PubMed ID: 10203353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.